Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Cefoperazone MeSH Descriptor Data 2025


MeSH Heading
Cefoperazone
Tree Number(s)
D02.065.589.099.249.150.160
D02.886.665.074.150.160
D03.633.100.300.249.150.160
Unique ID
D002438
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D002438
Scope Note
Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections.
Entry Term(s)
Cefobid
Cefoperazon
Cefoperazone Sodium
Cefoperazone Sodium Salt
Céfobis
T-1551
T1551
Pharm Action
Anti-Bacterial Agents
Registry Numbers
7U75I1278D
0
5FQG9774WD
Related Numbers
5FQG9774WD
62893-19-0
62893-20-3
CAS Type 1 Name
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-
Previous Indexing
Cephalosporins (1966-1983)
Public MeSH Note
84
History Note
84
Date Established
1984/01/01
Date of Entry
1983/04/04
Revision Date
2017/05/24
Cefoperazone Preferred
T1551 Narrower
Cefoperazone Sodium Narrower
Cefobid Narrower
page delivered in 0.156s